🔬 Science
1d ago
Common asthma drug shows promise for reversing fatty liver
Source ↗
👁 0
💬 0
MUSC researchers are tackling MASH, or metabolic dysfunction-associated steatohepatitis, a liver disease affecting hundreds of millions worldwide. It is also a leading cause of liver transplantation, yet treatment options remain limited.
Comments (0)